drugset / Trial / NCT05689242

Intravenous Nalbuphine Versus Intravenous Dexmedetomidine for Conscious Sedation in Patients Undergoing Colonoscopy

NCT05689242

Phase 4 Unknown 66 enrolled Assiut University
RandomizedFactorialTriple-blindOther

Summary

The aim of this study is to compare the sedative, analgesic effect and hemodynamic changes due to dexmedetomidine and nalbuphine during elective colonoscopy.

Timeline

Start
2023-03
Primary completion
2024-03
Completion
2024-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Nalbuphine Small molecule 0.2 mg/kg Intravenous

Indications

No indication recorded.